Ionis Pharmaceuticals (IONS) Net Cash Flow (2009 - 2026)

Ionis Pharmaceuticals' Net Cash Flow history runs 18 years deep, the most recent figure standing at -$198.7 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 1008.2% year-over-year to -$198.7 million; the TTM figure through Mar 2026 stood at -$91.1 million (down 7.52% YoY), while the FY2025 annual figure was $129.5 million, up 182.52% from the prior year.
• Net Cash Flow was -$198.7 million for Q1 2026 at Ionis Pharmaceuticals, down from $34.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $115.7 million in Q2 2023 to a low of -$326.5 million in Q1 2022.
• Historically, Net Cash Flow has averaged -$40.9 million across 5 years, with a median of -$20.2 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Net Cash Flow sank 2065.0% in 2022, then surged 673.14% in 2023.
• A 5-year view of Net Cash Flow shows it stood at -$39.1 million in 2022, then jumped by 219.99% to $46.9 million in 2023, then sank by 296.35% to -$92.0 million in 2024, then surged by 136.9% to $34.0 million in 2025, then plunged by 685.19% to -$198.7 million in 2026.
• The last three Net Cash Flow figures came in at -$198.7 million (Q1 2026), $34.0 million (Q4 2025), and $41.1 million (Q3 2025), per Business Quant data.